RBR-87b6r5s进行中（未招募）2 期
Oral Lamivudine for Diabetic Macular Edema: a Randomized Clinical Trial
niversidade Federal de São Paulo0 个研究点开始时间: 2021年12月7日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 0（—）
入选标准
- •18 years old and older without gender restriction; Type 1 or 2 diabetes; Diabetic macular edema with central involvement; Central retinal thickness equal to or greater than 325 µm measured by spectral-domain optical coherence tomography (SD-OCT); Best-corrected visual acuity less than 74 letters measured by the Early Treatment Diabetic Retinopathy Study (ETDRS) table.
排除标准
- •High-risk proliferative diabetic retinopathy; Hemoglobin A1c (HbA1c) greater than 12; History of panphotocoagulation, macular laser, anti-VEGF injection, or intraocular corticosteroid implant within the past 6 months; Presence of retinal alteration that, at the assistant physician's discretion, will not improve visual acuity even with the resolution of macular edema (foveal atrophy, condensation of foveal hard exudates); Diagnosis of ocular alteration, in addition to diabetic macular edema, which may alter visual acuity throughout the study (neovascular glaucoma, retinal vein occlusion, or uveitis); Positive serology for human immunodeficiency virus (HIV) or hepatitis B virus (HBV); Liver failure, or less than 40 mL/min/1,73 m2 estimated Glomerular Filtration Rate; History of lactic acidosis; Proven or suspected pregnancy, breastfeeding
研究者
相似试验
进行中（未招募）
不适用
Infliximab for Diabetic Macular Edema Refractory to Laser Photocoagulation: a Randomized, Double-Masked, Placebo-Controlled, Cross-over, 32 Weeks StudyDiabetic Macular OedemaMedDRA version: 8.1Level: LLTClassification code 10057915Term: Diabetic macular oedemaEUCTR2006-001182-41-GRAss.Prof. Petros Sfikakis
尚未招募
2 期
Treatment of Diabetic macular edema with intravitreal injection of antiangiogenic agents with or without DexamethasoneMacular EdemaC19.246.099DiabetesRBR-7468j4qniversidade Federal de Pernambuco
招募中
1 期
Treatment of Diabetic Macular Edema with Intraocular Injection of DexamethasoneMacular EdemaH360DiabetesRBR-59phz5cniversidade Federal de Pernambuco
进行中（未招募）
不适用
Tratamiento del edema de macula diabético clinicamente significativo con Ranibizumab (LUCENTIS) intravitreo. TREATMENT OF DIABETIC CLINICALLY SIGNIFICANT MACULAR EDEMA WITH INTRAVITREOUS RANIBIZUMAB (LUCENTIS)Edema de macula diabético refractario.REFRACTORY MACULAR EDEMA IN DIABETIC PATIENTSEUCTR2008-006879-71-ESHOSPITAL SAN PEDRO
进行中（未招募）
1 期
Comparison of the efficacy of treatment of retinal macular inflammation due to diabetes with ozurdex or with ozurdex plus laser treatment in the area.Diabetic macular edemaMedDRA version: 19.0 Level: LLT Classification code 10057934 Term: Diabetic macular edema System Organ Class: 100000004853EUCTR2016-003870-41-ESFundación para la Investigación Biomédica del Hospital Universitario Príncipe de Asturias30